Top compounds associated with response to CCDC17


Feature Type Standardized
Nominal ANOVA
mRNA BRD9647 CTRPv2 pan-cancer AAC -0.073 0.05
mRNA AZ628 GDSC1000 pan-cancer AAC -0.099 0.05
mRNA CGP-60474 GDSC1000 pan-cancer AAC 0.1 0.06
mRNA dabrafenib GDSC1000 pan-cancer AAC -0.058 0.06
mRNA SKI-II CTRPv2 pan-cancer AAC -0.068 0.06
mRNA docetaxel:tanespimycin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.06 0.07
mRNA Doxorubicin gCSI pan-cancer AAC -0.099 0.07
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.063 0.07
mRNA Midostaurin GDSC1000 pan-cancer AAC -0.064 0.07
mRNA SN-38 CTRPv2 pan-cancer AAC 0.066 0.07
Download CSV